Clinical Trials Using PIM/FLT3 Kinase Inhibitor SEL24
Clinical trials are research studies that involve people. The clinical trials on this list are studying PIM/FLT3 Kinase Inhibitor SEL24. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
SEL24 / MEN1703 in Patients With Acute Myeloid Leukemia
The purpose of the clinical trial is to identify the maximum tolerated dose of SEL24 / MEN1703 and to further investigate its safety profile in patients with Acute Myeloid Leukemia.
Location: 3 locations